InflaRx (IFRX) Assets (2016 - 2026)
InflaRx's (IFRX) quarterly Assets came in at $57.2 million in Q1 2026, down 37.45% year-on-year from $91.5 million in Q1 2025, and down 10.95% quarter-over-quarter from $64.3 million in Q4 2025.
InflaRx (IFRX) Assets (2016 - 2026) Analysis & Trends
InflaRx has disclosed Assets across 11 years of filings, most recently posting $57.2 million for Q1 2026.
- Assets for Q1 2026 came in at $57.2 million, down 37.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $57.2 million (down 37.45% YoY), and the FY2025 annual result was $64.3 million, down 20.88% from the prior year.
- Assets came in at $57.2 million for Q1 2026 at InflaRx, down from $64.3 million in the prior quarter.
- In the past five years, Assets ranged from a high of $144.8 million in Q2 2023 to a low of $57.2 million in Q1 2026.
- The 5-year median for Assets is $100.2 million (2024), against an average of $102.0 million.
- Across the five-year window, Assets advanced 25.81% in 2023 and sank 37.91% in 2024, its largest moves.
- InflaRx's Assets stood at $104.5 million in 2022, then advanced by 23.8% to $129.3 million in 2023, then plunged by 37.19% to $81.2 million in 2024, then declined by 20.88% to $64.3 million in 2025, then fell by 10.95% to $57.2 million in 2026.
- The last three Assets figures came in at $57.2 million (Q1 2026), $64.3 million (Q4 2025), and $76.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 37.37 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 811.27 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 14.93 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.73 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 33.89 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 23.64 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 12.81 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 26.48 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 640.56 Mn |
| 10 | InflaRx | 764.68 Mn | 764.68 Mn | 10,877.40 | 57.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.24 Mn |
| Dec 31, 2025 | 64.27 Mn |
| Sep 30, 2025 | 76.17 Mn |
| Jun 30, 2025 | 83.13 Mn |
| Mar 31, 2025 | 91.51 Mn |
| Dec 31, 2024 | 81.23 Mn |
| Sep 30, 2024 | 87.51 Mn |
| Jun 30, 2024 | 100.19 Mn |
| Mar 31, 2024 | 116.34 Mn |
| Dec 31, 2023 | 129.34 Mn |
| Sep 30, 2023 | 140.96 Mn |
| Jun 30, 2023 | 144.79 Mn |
| Mar 31, 2023 | 92.64 Mn |
| Dec 31, 2022 | 104.47 Mn |
| Sep 30, 2022 | 112.04 Mn |
| Jun 30, 2022 | 122.32 Mn |
| Mar 31, 2022 | 129.16 Mn |
| Dec 31, 2021 | 143.16 Mn |
| Sep 30, 2021 | 152.57 Mn |
| Jun 30, 2021 | 162.61 Mn |